Firbank MJ, Wiseman RM, Burton EJ, Saxby BK, O'Brien J T, Ford GA (2007). Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure: Brain atrophy, WMH change and blood pressure. Journal of Neurology. 254: 713-721.
Harrington F, Saxby BK, McKeith IG, Wesnes KA, Ford GA (2000). Cognitive performance in hypertensive and normotensive older subjects. Hypertension. 36: 1079-1082.
Hearing S, Wesnes KA, Bowman C (1999). Beta-blockers and cognitive function in elderly hypertensive patients: Withdrawal and consequences of ACE inhibitor substitution. International Journal of Geriatric Psychopharmacology. 2: 13-17.
Narayan SK, Saxby BK, Firbank MJ et al (2011). Plasma homocysteine and cognitive decline in older hypertensive subjects. International Psychogeriatrics 23: 1607–1615.
Pase MP, Pipingas A, Kras M, Nolidin K, Gibbs AL, Wesnes KA, Scholey AB, Stough C (2010) Healthy Middle-Aged Individuals are Vulnerable to Cognitive Deficits as a Result of Increased Arterial Stiffness. Journal of Hypertension 28: 1724-1729.
Saxby BK, Harrington F, McKeith IG, Wesnes KA, Ford GA (2003). Effects of hypertension on attention, memory, and executive function in older adults. Health Psychology. 22: 587-591.
Saxby BK, Harrington F, Wesnes KA, McKeith IG, Ford GA (2008). Candesartan and cognitive decline in older patients with hypertension. Neurology. 70: 1858-1866.
Rowan EN, Morris CM, Stephens S, Ballard C et al. (2005). Impact of hypertension and apolipoprotein E4 on post-stroke cognition in subjects >75 years of age. Stroke. 36: 1864-1868.